1. Home
  2. FGEN vs IPM Comparison

FGEN vs IPM Comparison

Compare FGEN & IPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • IPM
  • Stock Information
  • Founded
  • FGEN 1993
  • IPM 2005
  • Country
  • FGEN United States
  • IPM United States
  • Employees
  • FGEN N/A
  • IPM N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • IPM
  • Sector
  • FGEN Health Care
  • IPM
  • Exchange
  • FGEN Nasdaq
  • IPM NYSE
  • Market Cap
  • FGEN 33.5M
  • IPM 27.9M
  • IPO Year
  • FGEN 2014
  • IPM N/A
  • Fundamental
  • Price
  • FGEN $7.26
  • IPM $1.98
  • Analyst Decision
  • FGEN Strong Buy
  • IPM Strong Buy
  • Analyst Count
  • FGEN 1
  • IPM 1
  • Target Price
  • FGEN $250.00
  • IPM $6.00
  • AVG Volume (30 Days)
  • FGEN 74.1K
  • IPM 35.3K
  • Earning Date
  • FGEN 08-05-2025
  • IPM 08-13-2025
  • Dividend Yield
  • FGEN N/A
  • IPM N/A
  • EPS Growth
  • FGEN N/A
  • IPM N/A
  • EPS
  • FGEN N/A
  • IPM N/A
  • Revenue
  • FGEN $6,996,000.00
  • IPM $6,344,746.00
  • Revenue This Year
  • FGEN N/A
  • IPM $1,957.49
  • Revenue Next Year
  • FGEN N/A
  • IPM $17.96
  • P/E Ratio
  • FGEN N/A
  • IPM N/A
  • Revenue Growth
  • FGEN N/A
  • IPM 14.16
  • 52 Week Low
  • FGEN $4.50
  • IPM $1.52
  • 52 Week High
  • FGEN $38.25
  • IPM $5.50
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 60.54
  • IPM N/A
  • Support Level
  • FGEN $5.37
  • IPM N/A
  • Resistance Level
  • FGEN $5.73
  • IPM N/A
  • Average True Range (ATR)
  • FGEN 0.49
  • IPM 0.00
  • MACD
  • FGEN 0.27
  • IPM 0.00
  • Stochastic Oscillator
  • FGEN 83.80
  • IPM 0.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About IPM INTELLIGENT PROTECTION MANAGEMENT

Intelligent Protection Management Corp is a communications software innovator that powers multimedia social applications.

Share on Social Networks: